Key result
Prepregnancy high-fat feeding induced maternal obesity and significantly impaired the normal rise in maternal blood triglyceride concentrations during pregnancy by reducing ANGPTL4 expression in mice.
Why the study?
A lower increase in maternal blood triglyceride levels has been observed in some obese mothers, prompting investigation into if and how obesity alters maternal blood triglyceride levels.
p-value: p=<0.05
Maternal obesity impairs the physiological rise of maternal blood triglyceride concentrations during pregnancy by reducing ANGPTL4 expression, which increases LPL activity and blood TG clearance.
HF feeding during pregnancy reduces maternal TG; leaves open whether prepregnancy obesity modifies this effect or alters clinical risk.
To ensure fetal lipid supply, maternal blood triglyceride (TG) concentrations are robustly elevated during pregnancy. Interestingly, a lower increase in maternal blood TG concentrations has been observed in some obese mothers. We have shown that high-fat (HF) feeding during pregnancy significantly reduces maternal blood TG levels. Therefore, we performed this study to investigate if and how obesity alters maternal blood TG levels. Maternal obesity was established by prepregnant HF (ppHF) feeding, which avoided the dietary effect during pregnancy. We found not only that maternal blood TG concentrations in ppHF dams were remarkably lower than in control dams but also that the TG peak occurred earlier during gestation. Hepatic TG production and intestinal TG absorption were unchanged in ppHF dams, but systemic lipoprotein lipase (LPL) activity was increased, suggesting that increased blood TG clearance contributes to the decreased blood TG concentrations in ppHF dams. Although significantly higher levels of UCP1 protein were observed in interscapular brown adipose tissue (iBAT) of ppHF dams, Ucp1 gene deletion did not restore blood TG concentrations in ppHF dams. Expression of the angiopoietin-like protein 4 (ANGPTL4), a potent endogenous LPL inhibitor, was significantly increased during pregnancy. However, the pregnancy-induced elevation of blood TG was almost abolished in Angptl4−/− dams. Compared with control dams, Angptl4 mRNA levels were significantly lower in iBAT, gonadal white adipose tissue, and livers of ppHF dams. Importantly, ectopic overexpression of ANGPTL4 restored maternal blood TG concentrations in ppHF dams. Together, these results indicate that ANGPTL4 plays a vital role in increasing maternal blood TG concentrations during pregnancy. Obesity impairs the rise of maternal blood TG concentrations by reducing ANGPTL4 expression in mice.
No takes yet. Share an insight, caveat, or question.
Qiao et al. (2020) studied Maternal obesity and hypertriglyceridemia. Prepregnancy high-fat (ppHF) feeding vs. Ingredient-matched low-fat diet or regular chow was evaluated on Maternal blood triglyceride concentrations during pregnancy (p=<0.05). Prepregnancy high-fat feeding induced maternal obesity and significantly impaired the normal rise in maternal blood triglyceride concentrations during pregnancy by reducing ANGPTL4 expression in mice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: